scholarly journals Impact of Disease-Specific Fears on Pulmonary Rehabilitation Trajectories in Patients with COPD

2019 ◽  
Vol 8 (9) ◽  
pp. 1460 ◽  
Author(s):  
Thomas Janssens ◽  
Zora Van de Moortel ◽  
Wolfgang Geidl ◽  
Johannes Carl ◽  
Klaus Pfeifer ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Pulmonary Rehabilitation ◽  
Smoking Status ◽  
Symptom Burden ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Target Disease ◽  
Disease Specific

Disease-specific fears predict health status in chronic obstructive pulmonary disease (COPD), but their role in pulmonary rehabilitation (PR) remains poorly understood and especially longer-term evaluations are lacking. We therefore investigated changes in disease-specific fears over the course of PR and six months after PR, and investigated associations with PR outcomes (COPD assessment test (CAT) and St. Georges respiratory questionnaire (SGRQ)) in a subset of patients with COPD (n = 146) undergoing a 3-week inpatient PR program as part of the STAR study (Clinicaltrials.gov, ID: NCT02966561). Disease-specific fears as measured with the COPD anxiety questionnaire improved after PR. For fear of dyspnea, fear of physical activity and fear of disease progression, improvements remained significant at six-month follow-up. Patients with higher disease-specific fears at baseline showed elevated symptom burden (CAT and SGRQ Symptom scores), which persisted after PR and at follow-up. Elevated disease-specific fears also resulted in reduced improvements in Quality of Life (SGRQ activity and impact scales) after PR and at follow-up. Finally, improvement in disease-specific fears was associated with improvement in symptom burden and quality of life. Adjustment for potential confounding variables (sex, smoking status, age, lung function, and depressive symptoms) resulted in comparable effects. These findings show the role of disease-specific fears in patients with COPD during PR and highlight the need to target disease-specific fears to further improve the effects of PR.

scholarly journals EFFECT OF PULMONARY REHABILITATION IN PATIENTS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A HOSPITAL BASED CROSS SECTIONAL STUDY

2020 ◽  
pp. 1-4
Author(s):  
Ashish Kumar Dubey ◽  
Ravi Shankar Mishra*
Keyword(s):  
Quality Of Life ◽  
Chronic Obstructive Pulmonary Disease ◽  
Statistical Analysis ◽  
Pulmonary Rehabilitation ◽  
Chronic Obstructive ◽  
Walk Test ◽  
Borg Scale ◽  
Obstructive Pulmonary Disease

BACKGROUND: Chronic obstructive pulmonary disease(COPD) is an obstructive and progressive airway disease associated with reduction in daily physical activity and psychological problems related to patient's disability and poor quality of life. Pulmonary rehabilitation(PR) plays an essential role in the management of COPD, by breaking the vicious circle of dyspnea–decreased activity–deconditioning–isolation. AIM: This study aimed to highlight the impact of PR on COPD patients while focusing on the clinical usefulness of PR. MATERIALS & METHODS: This study was done over a period of 1.5 years including all the diagnosed cases of COPD (both OPD and IPD) who did not have any acute exacerbation requiring oxygen, not associated with other medical conditions such as heart disease, neurological disease, lumbar spondylitis or osteoarthritis or those unable to perform PFT after taking proper consent. The study was completed with a follow up schedule, monthly, for 3 months. Proforma for the study included demographics, history, examination, dyspnea grading using modied Borg scale as well as CAT questionnaire along with a six-minute walk test and spirometry. Statistical analysis was done using SPSS Version 20 (Chicago Inc., USA). Data comparison was done by applying specic statistical tests to nd out the statistical signicance of the comparisons. Quantitative variables were compared using mean values and qualitative variables using proportions. Signicance level was xed at P < 0.05. RESULTS: Out of total 227 cases, only 71 completed the 3-month monthly follow up and hence were used for the statistical analysis. The results showed male:female ratio 80.3:19.7. As per Borg scale, mean fever, chest pain, cough, expectoration and dyspnea score decreased over subsequent follow-up. Rate of hospitalisation was seen more in 61-70 year age group. Mean sixminute walk test value increased continuously during the duration of follow up. CONCLUSION: Effective pulmonary rehabilitation that incorporates exercise schedules and patient education compreh ensively can encompass treatment and improve the quality of life of patients suffering with COPD.

Pulmonary rehabilitation

2003 ◽  
Vol 13 (3) ◽  
pp. 175-182 ◽  
Author(s):  
Dipankar Dutta ◽  
Richard JA Butland ◽  
Ruma R Dutta ◽  
Miriam C Casey
Keyword(s):  
Quality Of Life ◽  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Rehabilitation ◽  
Exercise Programme ◽  
Chronic Respiratory Disease ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Multidisciplinary Education ◽  
Programme Of Care

Pulmonary rehabilitation is a multidisciplinary education and exercise programme of care for patients with chronic respiratory disease, particularly Chronic Obstructive Pulmonary Disease (COPD). It aims to reduce symptoms, decrease disability, increase participation in physical and social activities and improve overall quality of life in patients who may still be very disabled despite optimal pharmacological treatment. Pulmonary rehabilitation first began more than 30 years ago and is now established as an important part of the management of COPD.

Clustering effects of chronic obstructive pulmonary disease specific quality of life in hospitalized patients

Respirology ◽  
2003 ◽  
Vol 8 (3) ◽  
pp. 339-343 ◽  
Author(s):  
Adrian LOWE ◽  
Donald CAMPBELL ◽  
Pieter WALKER ◽  
Stephen FARISH ◽  
Bruce JACKSON ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Hospitalized Patients ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Disease Specific

scholarly journals Maintaining quality of life in patients with chronic obstructive pulmonary disease (COPD) by extending the maintenance phase of community-based pulmonary rehabilitation: protocol for a randomised controlled trial (ComEx3 Study)

2020 ◽  
Vol 7 (1) ◽  
pp. e000548
Author(s):  
Derrick Lopez ◽  
Nola Cecins ◽  
Joanne Cockram ◽  
Anna Collins ◽  
Holly Landers ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Chronic Obstructive Pulmonary Disease ◽  
Randomised Controlled Trial ◽  
Pulmonary Rehabilitation ◽  
Controlled Trial ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Randomised Controlled ◽  
Maintenance Programme

IntroductionPulmonary rehabilitation is a core component of the treatment of people with chronic obstructive pulmonary disease (COPD); however, the benefits gained diminish in the ensuing months. The optimal strategy for maintaining the benefits is unclear with weekly supervised maintenance exercise programmes proposed as one strategy. However, the long-term future of maintenance programs is dependent on quality evidence.Methods and analysisThe ComEx3 randomised controlled trial will investigate the efficacy of extending a weekly supervised maintenance programme for an additional 6 months following an initial 10-week maintenance programme (intervention) by comparing with a control group who receive the same 10-week maintenance programme followed by 6 months of usual care. 120 participants with COPD will be recruited. Primary objective is to determine health-related quality of life over 12 months. Secondary objectives are to determine functional exercise capacity trajectory and to perform an economic evaluation of the intervention to the health system. Outcomes will be analysed for superiority according to intention-to-treat and per-protocol approaches.Ethics and disseminationApproval has been received from the relevant ethics committees. Findings will be disseminated in peer-reviewed journals and conferences, targeting those involved in managing people with COPD as well as those who develop policies and guidelines.Clinical trial registrationANZCTR 12618000933257

Sign in / Sign up

Export Citation Format

Share Document